GSK3B and breast cancer: Consistent with these notions, NOP14 increased APC and β-catenin levels, as well as GSK-3β phosphorylation level in breast cancer cells; furthermore, NOP14 inhibited the entry of β-catenin into the nucleus of breast cancer cells (Figure 5).